https://news.x4a.net Mon, 26 Oct 2026 10:50:18 +0000 en-US hourly 1 https://news.x4a.net/marketwire/biontech-and-dualitybio-announce-topline-results-of-the-dynasty-breast02-global-phase-3/ Mon, 26 Oct 2026 10:50:18 +0000 https://news.x4a.net/marketwire/biontech-and-dualitybio-announce-topline-results-of-the-dynasty-breast02-global-phase-3/ BioNTech and DualityBio Announce Topline Results of the DYNASTY-Breast02 Global Phase 3 Clinical Trial Evaluating Trastuzumab Pamirtecan in HR+/HER2-low Metastatic Breast Cancer | $BNTX HKEX: 9606.HK

]]>